The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Markella Konstantinidou(University of California, San Francisco), Alexander Dömlingꝉ(University of Groningen), Frans ter Brake(University of Groningen), Asmaa Oun(University of Groningen), Amalia M. Dolga(University of Groningen), Zefeng Wang(Chinese Academy of Sciences), Arjan Kortholt(University of Groningen), Bidong Zhang(University of Groningen), Pragya Pathak(University of Groningen)
Cited by 42
Related Papers
Inhibition of Trypanosoma brucei Gene Expression by RNA Interference Using an Integratable Vector with Opposing T7 Promoters
|Journal of Biological Chemistry|2000|532
Covalent inhibitors: a rational approach to drug discovery
|RSC Medicinal Chemistry|2020|375
Pervasive translation of circular RNAs driven by short IRES-like elements
|Nature Communications|2022|220
PROTACs– a game-changing technology
|Expert Opinion on Drug Discovery|2019|159